For over two decades, François has helped clients in the life sciences and global healthcare industry innovate to transform operations, elevate global service strategies and optimize payor models. He specializes in helping clients mobilize integrated approaches to payor systems, pricing and market access.
François has spent over 20 years helping healthcare clients across a range of therapeutic areas and geographies around the globe. He assists his clients in navigating the complex global regulatory environment of life sciences, and in developing innovative, cross-functional planning strategies to commercialize innovative therapies.
Throughout his career, François’ work has spanned the therapy development continuum. He has helped many clients optimize their healthcare administration strategies in emerging and innovative markets around the globe, including the Group of Seven (G-7) and multinational groups across Brazil, Russia, India and China (BRIC). By balancing global and regulatory perspective, he helps his clients adopt a vision and a strategy for successfully navigating rare disease therapies, managing entry agreements and developing innovative contracting. He specializes in bringing the views of payors and other access stakeholders into focus while considering pharmaceutical perspectives on developing and commercializing innovative therapies.
Before joining Huron, François spent more than 13 years as a scientific investigator in health and nutrition sciences. Over the years, he has frequented panels, forums and speaking events throughout the United States, France and Spain.
François holds a doctorate in health and nutrition from the University of Paris and has contributed to many peer-reviewed publications. He also holds a degree of engineering in food sciences and in technology, as well as a diploma from the Market Research Society.